ArticleArchives of Iranian medicine2025
Efficacy and Safety Analysis of Triple Therapy (Pabolizumab+Cryoablation+Renvastinib) for Patients with Unresectable Hepatocellular Carcinoma (uHCC).
Juan Lei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.